Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
US8106076B2 · kind B2 · utility
0Cited by
8References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 17, 2009 |
| Grant date | Jan 31, 2012 |
| Priority date | — |
| Expiry date | Jul 31, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention provides a crystalline S-omeprazole strontium hydrate for the prevention or treatment of gastric acid-related diseases, which has high optical purity, theremostability, solubility and nonhygroscopicity, a method for preparing same, and a pharmaceutical composition containing same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.